BioSpace News Archive

First potential FEVR therapy to obtain U.S. Food and Drug Administration Orphan Drug Designation.

Marchand Institute emphasizes our commitment to diversity in our research, and encourages the promotion and recruitment of underrepresented cultures and ethnicities.

The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics (LT) announced two major initiatives to address underrepresentation of minorities in clinical trials and in the scientific research profession: Project CHANGE by LT and the Diversity in Lupus Research Program.

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for people with inherited systemic debilitating diseases, today announced that it will deliver a platform presentation and two poster presentations at the 18th Annual WORLDSymposium™.

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs, today reported financial results for the fourth quarter and fiscal year ended November 30, 2021 and provided a corporate update.

ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2021.

Salona Global Medical Device is pleased to announce that it has entered into an agreement with a syndicate of underwriters pursuant to which the Underwriters have agreed to purchase for resale, on a bought deal private placement basis an aggregate of 7,280,000 units (“Units”) at a price of $0.55 per Unit (the “Issue Price”) for aggregate gross proceeds to the Company of $4,004,000 (the “Offering”).

LUNGevity Foundation is partnering for the third time with the patient-led registered nonprofit organization ALK Positive to support the ALK-Positive Lung Cancer Research Award Program.

Trinity Biotech plc today announced that it has closed its recently announced refinancing.

Quipt Home Medical Corp. today announced its fourth quarter and fiscal year 2021 financial results and operational highlights and filing of its annual financial statements.